Projects per year
Personal profile
Research area keywords
- Epilepsy
- Neurocognitive disorders
- Biostatistics
- Neuropsychology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
-
Transforming CAR-T Service Delivery: Integrated Biomarker and Clinical Tools for Prediction and Management of Neurotoxicity
Monif, M. (Primary Chief Investigator (PCI)), Spencer, A. (Chief Investigator (CI)), Ho, P. J. (Chief Investigator (CI)), Turtle, C. (Chief Investigator (CI)), Malpas, C. (Chief Investigator (CI)), Darby, D. (Chief Investigator (CI)), Wright, D. (Chief Investigator (CI)), Kerridge, I. H. (Chief Investigator (CI)), Fiorenza, S. (Chief Investigator (CI)), Westworth, M. (Chief Investigator (CI)), Kazzi, C. (Associate Investigator (AI)), Simpson, T. (Associate Investigator (AI)), Sanfilippo, P. (Associate Investigator (AI)), Cherk, M. (Associate Investigator (AI)), Henderson, M. (Associate Investigator (AI)), O'Brien, T. (Associate Investigator (AI)), Morison, J. (Associate Investigator (AI)), Schoenwaelder, M. (Associate Investigator (AI)), Winton, S. (Associate Investigator (AI)) & Blum, S. (Associate Investigator (AI))
1/10/26 → 30/09/30
Project: Research
-
Australian Autoimmune Encephalitis Consortium Study - improving diagnosis, outcomes, and quality of care for patients with this devastating neurological illness.
Monif, M. (Primary Chief Investigator (PCI)), Wesselingh, R. (Chief Investigator (CI)), Butzkueven, H. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Malpas, C. (Chief Investigator (CI)), Haartsen, J. (Chief Investigator (CI)), Hardy, T. (Chief Investigator (CI)), Gillis, D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Blum, S. (Chief Investigator (CI)), Nesbitt, C. S. (Chief Investigator (CI)), Heiss, L. (Chief Investigator (CI)), MacDonell, R. (Chief Investigator (CI)), Mykytowycz, M. (Chief Investigator (CI)), Sanfilippo, P. (Chief Investigator (CI)), D'Souza, W. J. (Associate Investigator (AI)), Kulkarni, J. (Associate Investigator (AI)), Buzzard, K. (Associate Investigator (AI)), O'Brien, T. (Associate Investigator (AI)), Broadley, S. (Associate Investigator (AI)), Taylor, B. V. (Associate Investigator (AI)), MacIntyre, J. (Associate Investigator (AI)), Barton, J. (Associate Investigator (AI)), Swayne, A. (Associate Investigator (AI)), Alpitsis, R. (Associate Investigator (AI)), Harding, I. (Associate Investigator (AI)), Butler, E. (Associate Investigator (AI)), Ramanathan, S. (Associate Investigator (AI)), Giles, A. (Associate Investigator (AI)) & Gadi, M. (Associate Investigator (AI))
1/03/24 → 28/02/29
Project: Research
-
A Phase 2, double-blind, placebo-controlled trial of sodium selenate as a disease modifying treatment for chronic drug resistant temporal lobe epilepsy (SELECT Trial)
O'Brien, T. (Primary Chief Investigator (PCI)), Vivash, L. (Chief Investigator (CI)), Churilov, L. (Chief Investigator (CI)), Kwan, P. (Chief Investigator (CI)), Carney, P. (Chief Investigator (CI)), Perucca, P. (Chief Investigator (CI)), Nicolo, J.-P. (Chief Investigator (CI)), Cook, M. J. (Chief Investigator (CI)), Gillinder, L. (Chief Investigator (CI)), Casillas-Espinosa, P. (Chief Investigator (CI)), Hovens, C. (Chief Investigator (CI)), Malpas, C. (Chief Investigator (CI)), Shultz, S. (Chief Investigator (CI)), Velakoulis, D. (Chief Investigator (CI)), Lawn, N. D. (Chief Investigator (CI)), Johns, H. (Associate Investigator (AI)), Wijayath, M. (Associate Investigator (AI)), Burford, J. (Associate Investigator (AI)), Wait, L. (Associate Investigator (AI)), D'Souza, W. J. (Associate Investigator (AI)) & Reutens, D. C. (Associate Investigator (AI))
1/02/23 → 31/01/28
Project: Research
-
Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP)
O'Brien, T. (Primary Chief Investigator (PCI)), Bertram, K. (Chief Investigator (CI)), Vivash, L. (Chief Investigator (CI)), Evans, A. H. (Chief Investigator (CI)), Kimber, T. E. (Chief Investigator (CI)), O'Sullivan, J. D. (Chief Investigator (CI)), Malpas, C. (Chief Investigator (CI)), Fielding, J. (Chief Investigator (CI)), Velakoulis, D. (Chief Investigator (CI)) & Law, M. (Chief Investigator (CI))
1/06/20 → 31/05/27
Project: Research
-
Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)
O'Brien, T. (Primary Chief Investigator (PCI)), Malpas, C. (Chief Investigator (CI)), Velakoulis, D. (Chief Investigator (CI)), Piguet, O. (Chief Investigator (CI)), Kalincik, T. (Chief Investigator (CI)), Walterfang, M. A. (Chief Investigator (CI)), Ahmed, R. (Chief Investigator (CI)), Bush, A. I. (Chief Investigator (CI)), Darby, D. (Chief Investigator (CI)) & Brodtmann, A. (Chief Investigator (CI))
Department of Health, Disability and Ageing (Australia)
1/04/19 → 31/03/27
Project: Research
-
Clarifications and response to “Validating plasma biomarkers for distinguishing neurodegenerative and psychiatric disorders” by Boccardi et al.
Eratne, D., Kang, M., Malpas, C. B., Dang, C., Santillo, A. F., Zetterberg, H., Velakoulis, D. & The MiND Study Group, Apr 2026, In: Alzheimer's & Dementia. 22, 4, 4 p., e71375.Research output: Contribution to journal › Letter › Other › peer-review
Open Access -
Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Utility for Subacute Cognitive Monitoring after Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T-Cell Therapy
Kazzi, C., Griffith, S. P., Ko, K. Y., Pearce, D. J., Wronski, M., Seery, N., Wesselingh, R., Tan, T. H., Simpson, T., Abbott, C., Li, J., Cole, E., Westworth, M., Inam, S., Rushen, T., Parsons, S., Melitsis, L., Wong, S. M., Butzkueven, H. & Van Der Walt, A. & 8 others, , Apr 2026, In: Transplantation and Cellular Therapy. 32, 4, p. 436-445 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study
Seery, N., Wesselingh, R., Beech, P., McLaughlin, L. M., Rushen, T., Halliday, A. J., Horst, L. T., Griffith, S. P., Forcadela, M., Tan, T. H., Kazzi, C., Nesbitt, C., Broadley, J., Buzzard, K., Duncan, A. J., D'Souza, W. J., Tran, Y. D., Van Der Walt, A., Skinner, G. & Taylor, B. V. & 17 others, , 19 Jun 2025, In: Neurology: Neuroimmunology and NeuroInflammation. 12, 4, 12 p., e200412.Research output: Contribution to journal › Article › Research › peer-review
Open Access19 Link opens in a new tab Citations (Scopus) -
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
Cilia, B. J., Eratne, D., Wannan, C., Malpas, C., Janelidze, S., Hansson, O., Everall, I., Bousman, C., Thomas, N., Santillo, A. F., Velakoulis, D. & Pantelis, C., Mar 2025, In: Australian and New Zealand Journal of Psychiatry. 59, 3, p. 248-259 12 p.Research output: Contribution to journal › Article › Research › peer-review
3 Link opens in a new tab Citations (Scopus) -
CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T-cell therapy
Kazzi, C., Simpson, T., Wronski, M., Seery, N., Wesselingh, R., Tan, T. H., Ko, K. Y., Pearce, D. J., Abbott, C., Li, J., Griffith, S. P., Wong, S. M., Westworth, M., Inam, S., Tam, C. S., Fleming, S., Van Der Walt, A., O'Brien, T. J., Alpitsis, R. & Spencer, A. & 3 others, , Oct 2025, In: British Journal of Haematology. 207, 4, p. 1495-1503 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)